Complete Cytoreductive Surgery Is Feasible and Maximizes Survival in Patients with Advanced Epithelial Ovarian Cancer: A Prospective Study
- 1 May 1998
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 69 (2), 103-108
- https://doi.org/10.1006/gyno.1998.4955
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Second-Look Laparotomy for Ovarian Cancer Provides Reliable Prognostic Information and Improves SurvivalGynecologic Oncology, 1997
- Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinomaCancer, 1994
- Peritoneal Implant Elimination during Cytoreductive Surgery for Ovarian Cancer: Impact on SurvivalGynecologic Oncology, 1993
- Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.Journal of Clinical Oncology, 1992
- The Role of Hexamethylmelamine in the Combination Chemotherapy of Advanced Ovarian CancerAmerican Journal of Clinical Oncology, 1990
- Resection of diaphragmatic peritoneum and muscle: Role in cytoreductive surgery for ovarian cancerGynecologic Oncology, 1989
- Outcome of primary cytoreduction surgery for advanced epithelial ovarian carcinomaCleveland Clinic Journal of Medicine, 1988
- Prognostic factors in advanced ovarian carcinoma.Journal of Clinical Oncology, 1986
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- Surgical treatment of ovarian cancerGynecologic Oncology, 1973